Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2015-10-12

Clinical Trial Update: Potassium Citrate Supplementation vs. Dietary Counseling [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating potassium citrate supplementation versus dietary counseling for nephrolithiasis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • POTASSIUM CITRATE (Potassium citrate)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Kidney Stone | Phase 2 | Status: WITHDRAWN